Quick Cases: Key Concepts in the Contemporary Management of HIV
  • Program Overview
    Quick Cases: Key Concepts in the Contemporary Management of HIV
    This collection of case-based expert commentaries reinforces core concepts relevant to the contemporary management of HIV.

Latest Content

10 of 21 Shown
  • How New Data From IAS 2017 May Inform Dual-Therapy Options for HIV Treatment

    Daniel R. Kuritzkes MD - 9/12/2017 3 comments / Last Comment: 10/16/2017
    Should dual-therapy ART be considered in the first-line setting for some patients?
  • How New Data From IAS 2017 May Inform Use of ART in Patients With Cardiovascular or Bone Comorbidities

    Daniel R. Kuritzkes MD - 9/11/2017 2 comments / Last Comment: 10/16/2017
    Can switching ART improve cardiovascular or bone health?
  • IAS 2017 Data Shed Light on the Potential Use of Investigational ART Coformulations

    Daniel R. Kuritzkes MD - 9/11/2017 2 comments / Last Comment: 10/16/2017
    How do phase III data on bictegravir and doravirine affect the potential future HIV treatment landscape? Here’s my take.
  • Weighing Boosted vs Unboosted Options for a Patient Who Requires Treatment Prior to Availability of Resistance Data

    Eric S. Daar MD - 6/21/2017 2 comments / Last Comment: 9/12/2017
    For a newly diagnosed patient with an OI and pending resistance test results, when and with what would you recommend initiating ART?
  • Optimizing ART for a Patient With PI Intolerance and a History of Resistance and Nonadherence

    Eric S. Daar MD - 6/21/2017 1 comment / Last Comment: 6/22/2017
    Would you switch a virologically suppressed patient who is experiencing PI toxicity to a PI-sparing regimen if they had a history of nonadherence and resistance?
  • Weighing Boosted vs Unboosted Options for a Patient With Comorbidities Who Desires an STR

    Eric S. Daar MD - 6/21/2017 1 comment / Last Comment: 9/12/2017
    What is the optimal ART regimen for a patient with CKD and CVD who desires an STR?
  • Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk

    David A. Wohl MD - 6/1/2017 2 comments / Last Comment: 8/16/2017
    Which statins should be avoided in patients receiving boosted ART regimens?
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017 3 comments / Last Comment: 7/31/2017
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?
  • Adopting Lung Cancer Screening Recommendations for an HIV-Infected Individual With a Smoking History

    David A. Wohl MD - 5/31/2017
    What qualifies an HIV-infected past or current smoker for annual lung cancer screening using low-dose CT scans?
  • ART Switch for Comorbidities in a Middle-Aged Black Woman

    Lisa Hightow-Weidman MD, MPH - 5/12/2017 2 comments / Last Comment: 9/11/2017
    One-tablet regimens may not always be the best choice of ART, but the best choice is always the one the patient is willing to take.
10 of 21 Shown
Show 10 More
Loading...